XTEND: Two-Year Results from a Global Observational Study Investigating Proactive Dosing of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration.
OPHTHALMOLOGY AND THERAPY（2024）
Key words
Aflibercept,Age-related macular degeneration,Clinical trial,Intravitreal,Macula,Neovascularization,Retina,Vision
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined